Araya Puwanant to Humans
This is a "connection" page, showing publications Araya Puwanant has written about Humans.
Connection Strength
0.209
-
Puwanant A, Isfort M, Lacomis D, Živkovic SA. Clinical spectrum of neuromuscular complications after immune checkpoint inhibition. Neuromuscul Disord. 2019 02; 29(2):127-133.
Score: 0.038
-
Lacomis D, Puwanant A. What is in the Neuromuscular Junction Literature? J Clin Neuromuscul Dis. 2018 Dec; 20(2):76-84.
Score: 0.038
-
Puwanant A, Herrmann DN. Multifocal acquired demyelinating sensory and motor neuropathy. Neurology. 2012 Oct 16; 79(16):1742.
Score: 0.025
-
Puwanant A, Evangelisti SM, Griggs RC. Treating the chief complaint: hand rejuvenation for Hirayama disease. Neurology. 2011 Jul 12; 77(2):190-1.
Score: 0.023
-
Puwanant A, Ruff RL. INa and IKir are reduced in Type 1 hypokalemic and thyrotoxic periodic paralysis. Muscle Nerve. 2010 Sep; 42(3):315-27.
Score: 0.021
-
Heatwole C, Luebbe E, Rosero S, Eichinger K, Martens W, Hilbert J, Dekdebrun J, Dilek N, Zizzi C, Johnson N, Puwanant A, Tawil R, Schifitto G, Beck CA, Richeson JF, Zareba W, Thornton C, McDermott MP, Moxley R. Mexiletine in Myotonic Dystrophy Type 1: A Randomized, Double-Blind, Placebo-Controlled Trial. Neurology. 2021 01 12; 96(2):e228-e240.
Score: 0.011
-
Simmons DB, Lanning J, Cleland JC, Puwanant A, Twydell PT, Griggs RC, Tawil R, Logigian EL. Long Exercise Test in Periodic Paralysis: A Bayesian Analysis. Muscle Nerve. 2019 01; 59(1):47-54.
Score: 0.009
-
Gonzalez NL, Puwanant A, Lu A, Marks SM, Živkovic SA. Myasthenia triggered by immune checkpoint inhibitors: New case and literature review. Neuromuscul Disord. 2017 Mar; 27(3):266-268.
Score: 0.008
-
Harada Y, Puwanant A, Herrmann DN. Hereditary Neuropathy With Liability to Pressure Palsies: Diverse Phenotypes in Childhood. J Clin Neuromuscul Dis. 2016 Dec; 18(2):79-83.
Score: 0.008
-
Heatwole C, Bode R, Johnson NE, Dekdebrun J, Dilek N, Eichinger K, Hilbert JE, Logigian E, Luebbe E, Martens W, Mcdermott MP, Pandya S, Puwanant A, Rothrock N, Thornton C, Vickrey BG, Victorson D, Moxley RT. Myotonic dystrophy health index: Correlations with clinical tests and patient function. Muscle Nerve. 2016 Feb; 53(2):183-90.
Score: 0.008
-
Nakamori M, Sobczak K, Puwanant A, Welle S, Eichinger K, Pandya S, Dekdebrun J, Heatwole CR, McDermott MP, Chen T, Cline M, Tawil R, Osborne RJ, Wheeler TM, Swanson MS, Moxley RT, Thornton CA. Splicing biomarkers of disease severity in myotonic dystrophy. Ann Neurol. 2013 Dec; 74(6):862-72.
Score: 0.007
-
Murphy SM, Puwanant A, Griggs RC. Unintended effects of orphan product designation for rare neurological diseases. Ann Neurol. 2012 Oct; 72(4):481-90.
Score: 0.006
-
Koubeissi MZ, Puwanant A, Jehi L, Alshekhlee A. In-hospital complications of epilepsy surgery: a six-year nationwide experience. Br J Neurosurg. 2009; 23(5):524-9.
Score: 0.005
-
Kusner LL, Puwanant A, Kaminski HJ. Ocular myasthenia: diagnosis, treatment, and pathogenesis. Neurologist. 2006 Sep; 12(5):231-9.
Score: 0.004